Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues

Elena Milanesi, Roberta Zanardini, Gianluca Rosso, Giuseppe Maina, Alessandro Barbon, Cristina Mora, Alessandra Minelli, Massimo Gennarelli, Luisella Bocchio-Chiavetto

Research output: Contribution to journalArticle

Abstract

Objectives: Insulin-like growth factor binding protein 2 (IGFBP2) is a member of the family of high-affinity binding proteins (IGFBP1–6) and appears to play a governing role in insulin-like growth factor (IGF) regulation in the central nervous system. This study aimed to investigate the putative involvement of IGFBP2 in mood disorder pathogenesis by measuring its expression levels in patient peripheral tissues. Methods: IGFBP2 protein and mRNA levels were measured in the serum of 93 controls, 41 bipolar disorder (BD) and 43 major depressive disorder (MDD) patients and in the skin fibroblasts from 15 controls, 12 BD and 23 MDD patients. Results: The results indicated reduced expression of IGFBP2 in both tissues of BD patients, whereas no difference was found in MDD patients compared with controls. Conclusions: Our findings in peripheral tissues are consistent with previous results in the brain and support a downregulation of IGFBP2 expression that is specific for BD, suggesting a role for this protein in the alterations in neurodevelopment and neuroprotection observed in the disorder. Further studies in independent and larger cohorts are warranted to confirm the involvement of IGFBP2 in BD.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalWorld Journal of Biological Psychiatry
DOIs
Publication statusE-pub ahead of print - Feb 15 2017

Fingerprint

Insulin-Like Growth Factor Binding Protein 2
Bipolar Disorder
Major Depressive Disorder
Somatomedins
Mood Disorders
Carrier Proteins
Proteins
Down-Regulation
Central Nervous System
Fibroblasts
Messenger RNA
Skin
Brain
Serum

Keywords

  • bipolar disorder
  • fibroblasts
  • IGFBP2
  • major depressive disorder
  • serum

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Insulin-like growth factor binding protein 2 in bipolar disorder : An expression study in peripheral tissues. / Milanesi, Elena; Zanardini, Roberta; Rosso, Gianluca; Maina, Giuseppe; Barbon, Alessandro; Mora, Cristina; Minelli, Alessandra; Gennarelli, Massimo; Bocchio-Chiavetto, Luisella.

In: World Journal of Biological Psychiatry, 15.02.2017, p. 1-9.

Research output: Contribution to journalArticle

@article{351c7c20ed3c49ecadc2a30156df6b91,
title = "Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues",
abstract = "Objectives: Insulin-like growth factor binding protein 2 (IGFBP2) is a member of the family of high-affinity binding proteins (IGFBP1–6) and appears to play a governing role in insulin-like growth factor (IGF) regulation in the central nervous system. This study aimed to investigate the putative involvement of IGFBP2 in mood disorder pathogenesis by measuring its expression levels in patient peripheral tissues. Methods: IGFBP2 protein and mRNA levels were measured in the serum of 93 controls, 41 bipolar disorder (BD) and 43 major depressive disorder (MDD) patients and in the skin fibroblasts from 15 controls, 12 BD and 23 MDD patients. Results: The results indicated reduced expression of IGFBP2 in both tissues of BD patients, whereas no difference was found in MDD patients compared with controls. Conclusions: Our findings in peripheral tissues are consistent with previous results in the brain and support a downregulation of IGFBP2 expression that is specific for BD, suggesting a role for this protein in the alterations in neurodevelopment and neuroprotection observed in the disorder. Further studies in independent and larger cohorts are warranted to confirm the involvement of IGFBP2 in BD.",
keywords = "bipolar disorder, fibroblasts, IGFBP2, major depressive disorder, serum",
author = "Elena Milanesi and Roberta Zanardini and Gianluca Rosso and Giuseppe Maina and Alessandro Barbon and Cristina Mora and Alessandra Minelli and Massimo Gennarelli and Luisella Bocchio-Chiavetto",
year = "2017",
month = "2",
day = "15",
doi = "10.1080/15622975.2017.1282172",
language = "English",
pages = "1--9",
journal = "World Journal of Biological Psychiatry",
issn = "1562-2975",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Insulin-like growth factor binding protein 2 in bipolar disorder

T2 - An expression study in peripheral tissues

AU - Milanesi, Elena

AU - Zanardini, Roberta

AU - Rosso, Gianluca

AU - Maina, Giuseppe

AU - Barbon, Alessandro

AU - Mora, Cristina

AU - Minelli, Alessandra

AU - Gennarelli, Massimo

AU - Bocchio-Chiavetto, Luisella

PY - 2017/2/15

Y1 - 2017/2/15

N2 - Objectives: Insulin-like growth factor binding protein 2 (IGFBP2) is a member of the family of high-affinity binding proteins (IGFBP1–6) and appears to play a governing role in insulin-like growth factor (IGF) regulation in the central nervous system. This study aimed to investigate the putative involvement of IGFBP2 in mood disorder pathogenesis by measuring its expression levels in patient peripheral tissues. Methods: IGFBP2 protein and mRNA levels were measured in the serum of 93 controls, 41 bipolar disorder (BD) and 43 major depressive disorder (MDD) patients and in the skin fibroblasts from 15 controls, 12 BD and 23 MDD patients. Results: The results indicated reduced expression of IGFBP2 in both tissues of BD patients, whereas no difference was found in MDD patients compared with controls. Conclusions: Our findings in peripheral tissues are consistent with previous results in the brain and support a downregulation of IGFBP2 expression that is specific for BD, suggesting a role for this protein in the alterations in neurodevelopment and neuroprotection observed in the disorder. Further studies in independent and larger cohorts are warranted to confirm the involvement of IGFBP2 in BD.

AB - Objectives: Insulin-like growth factor binding protein 2 (IGFBP2) is a member of the family of high-affinity binding proteins (IGFBP1–6) and appears to play a governing role in insulin-like growth factor (IGF) regulation in the central nervous system. This study aimed to investigate the putative involvement of IGFBP2 in mood disorder pathogenesis by measuring its expression levels in patient peripheral tissues. Methods: IGFBP2 protein and mRNA levels were measured in the serum of 93 controls, 41 bipolar disorder (BD) and 43 major depressive disorder (MDD) patients and in the skin fibroblasts from 15 controls, 12 BD and 23 MDD patients. Results: The results indicated reduced expression of IGFBP2 in both tissues of BD patients, whereas no difference was found in MDD patients compared with controls. Conclusions: Our findings in peripheral tissues are consistent with previous results in the brain and support a downregulation of IGFBP2 expression that is specific for BD, suggesting a role for this protein in the alterations in neurodevelopment and neuroprotection observed in the disorder. Further studies in independent and larger cohorts are warranted to confirm the involvement of IGFBP2 in BD.

KW - bipolar disorder

KW - fibroblasts

KW - IGFBP2

KW - major depressive disorder

KW - serum

UR - http://www.scopus.com/inward/record.url?scp=85012873212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012873212&partnerID=8YFLogxK

U2 - 10.1080/15622975.2017.1282172

DO - 10.1080/15622975.2017.1282172

M3 - Article

AN - SCOPUS:85012873212

SP - 1

EP - 9

JO - World Journal of Biological Psychiatry

JF - World Journal of Biological Psychiatry

SN - 1562-2975

ER -